Hallucinogenic drugs in psychiatric research and treatment. Perspectives and prospects
- PMID: 7891058
- DOI: 10.1097/00005053-199503000-00002
Hallucinogenic drugs in psychiatric research and treatment. Perspectives and prospects
Abstract
Clinical research with hallucinogens has resumed after a generation's hiatus. To place these new studies in context, this article reviews the history of hallucinogens' use and abuse, discusses their pharmacological properties, and highlights previous human studies. Research with lysergic acid diethylamide and related hallucinogens with thousands of patients and control subjects was associated with acceptable safety when subjects were carefully screened, supervised, and followed up. Data were generated regarding hallucinogens' psychopharmacology, overlap with endogenous psychoses, and psychotherapeutic efficacy. Current American and European studies emphasize systematic psychopharmacology, in addition to psychotherapy protocols. Human hallucinogen research will help define unique mind-brain interfaces, and provide mechanistic hypotheses and treatment options for psychiatric disorders. It is critical that human hallucinogen research in the 1990s make use of state of the art methodologies, or consensually define when modifications are required. Training and supervisory issues also must be explicitly addressed.
Similar articles
-
Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).ACS Chem Neurosci. 2018 Oct 17;9(10):2331-2343. doi: 10.1021/acschemneuro.8b00043. Epub 2018 Mar 1. ACS Chem Neurosci. 2018. PMID: 29461039 Review.
-
Can psychedelics have a role in psychiatry once again?Br J Psychiatry. 2005 Jun;186:457-8. doi: 10.1192/bjp.186.6.457. Br J Psychiatry. 2005. PMID: 15928353 No abstract available.
-
A role for psychedelics in psychiatry?Br J Psychiatry. 2005 Nov;187:483; author reply 484-5. doi: 10.1192/bjp.187.5.483-a. Br J Psychiatry. 2005. PMID: 16260828 No abstract available.
-
The future of hallucination research: Can hallucinogens and psychedelic drugs teach us anything?Psychiatry Res. 2023 Jan;319:114968. doi: 10.1016/j.psychres.2022.114968. Epub 2022 Nov 20. Psychiatry Res. 2023. PMID: 36462291
-
Therapeutic Potential of Psychedelics in the Treatment of Psychiatric Disorders, Part 1: Psychopharmacology and Neurobiological Effects.J Clin Psychiatry. 2021 Feb 23;82(2):20ac13786. doi: 10.4088/JCP.20ac13786. J Clin Psychiatry. 2021. PMID: 33988926 Review. No abstract available.
Cited by
-
Psilocybin's effects on cognition and creativity: A scoping review.J Psychopharmacol. 2023 Jul;37(7):635-648. doi: 10.1177/02698811231179801. Epub 2023 Jul 3. J Psychopharmacol. 2023. PMID: 37395359 Free PMC article. Review.
-
Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults.Curr Top Behav Neurosci. 2022;56:71-92. doi: 10.1007/7854_2021_269. Curr Top Behav Neurosci. 2022. PMID: 34761363
-
Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine.Ther Adv Psychopharmacol. 2021 Jan 25;11:2045125320986634. doi: 10.1177/2045125320986634. eCollection 2021. Ther Adv Psychopharmacol. 2021. PMID: 33717431 Free PMC article.
-
DMT alters cortical travelling waves.Elife. 2020 Oct 12;9:e59784. doi: 10.7554/eLife.59784. Elife. 2020. PMID: 33043883 Free PMC article.
-
Ceremonial "plant medicine" use and its relationship to recreational drug use: an exploratory study.Addict Res Theory. 2019;27(2):68-75. doi: 10.1080/16066359.2018.1455187. Epub 2018 Mar 30. Addict Res Theory. 2019. PMID: 31534445 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical